AngioDynamics Inc (ANGO) - Total Assets
Based on the latest financial reports, AngioDynamics Inc (ANGO) holds total assets worth $260.68 Million USD as of February 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check AngioDynamics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
AngioDynamics Inc - Total Assets Trend (2002–2025)
This chart illustrates how AngioDynamics Inc's total assets have evolved over time, based on quarterly financial data. Check ANGO cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
AngioDynamics Inc - Asset Composition Analysis
Current Asset Composition (May 2025)
AngioDynamics Inc's total assets of $260.68 Million consist of 60.1% current assets and 39.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 20.0% |
| Accounts Receivable | $43.14 Million | 15.4% |
| Inventory | $62.01 Million | 22.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $69.12 Million | 24.7% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2002–2025)
This chart illustrates how AngioDynamics Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ANGO market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: AngioDynamics Inc's current assets represent 60.1% of total assets in 2025, a decrease from 76.9% in 2002.
- Cash Position: Cash and equivalents constituted 20.0% of total assets in 2025, up from 7.4% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 24.0% of total assets, an increase from 5.0% in 2002.
- Asset Diversification: The largest asset category is intangible assets at 24.7% of total assets.
AngioDynamics Inc Competitors by Total Assets
Key competitors of AngioDynamics Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
QITIAN Technology Group Co Ltd
SHE:300061
|
China | CN¥1.17 Billion |
|
Visco Vision Inc.
TW:6782
|
Taiwan | NT$5.82 Billion |
|
Daxor Corporation
NASDAQ:DXR
|
USA | $35.90 Million |
|
GETS Global Bhd
KLSE:5079
|
Malaysia | RM400.10 Million |
|
Osteopore Ltd
AU:OSX
|
Australia | AU$2.77 Million |
|
Safe Orthopaedics SA
PA:ALSAF
|
France | €7.94 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$279.25 Million |
AngioDynamics Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.35 | 2.21 | 2.45 |
| Quick Ratio | 1.47 | 1.40 | 1.60 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $89.49 Million | $94.30 Million | $83.30 Million |
AngioDynamics Inc - Advanced Valuation Insights
This section examines the relationship between AngioDynamics Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.66 |
| Latest Market Cap to Assets Ratio | 1.60 |
| Asset Growth Rate (YoY) | -11.8% |
| Total Assets | $280.14 Million |
| Market Capitalization | $447.90 Million USD |
Valuation Analysis
Above Book Valuation: The market values AngioDynamics Inc's assets above their book value (1.60x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: AngioDynamics Inc's assets decreased by 11.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for AngioDynamics Inc (2002–2025)
The table below shows the annual total assets of AngioDynamics Inc from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-05-31 | $280.14 Million | -11.81% |
| 2024-05-31 | $317.67 Million | -40.36% |
| 2023-05-31 | $532.64 Million | -3.64% |
| 2022-05-31 | $552.75 Million | -1.55% |
| 2021-05-31 | $561.44 Million | -5.72% |
| 2020-05-31 | $595.51 Million | -28.80% |
| 2019-05-31 | $836.44 Million | +18.56% |
| 2018-05-31 | $705.47 Million | -0.35% |
| 2017-05-31 | $707.96 Million | -2.76% |
| 2016-05-31 | $728.06 Million | -5.89% |
| 2015-05-31 | $773.62 Million | -3.32% |
| 2014-05-31 | $800.16 Million | +1.04% |
| 2013-05-31 | $791.88 Million | +9.21% |
| 2012-05-31 | $725.08 Million | +65.71% |
| 2011-05-31 | $437.55 Million | +3.21% |
| 2010-05-31 | $423.93 Million | +3.72% |
| 2009-05-31 | $408.70 Million | -0.01% |
| 2008-05-31 | $408.75 Million | +6.64% |
| 2007-05-31 | $383.28 Million | +179.77% |
| 2006-05-31 | $137.00 Million | +129.59% |
| 2005-05-31 | $59.67 Million | +20.00% |
| 2004-05-31 | $49.73 Million | +83.79% |
| 2003-05-31 | $27.06 Million | +31.04% |
| 2002-05-31 | $20.65 Million | -- |
About AngioDynamics Inc
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall … Read more